Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco Dorsey Wright Momentum ETF
PDP
|
+$591M |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$240M |
| 3 |
Boston Scientific
BSX
|
+$194M |
| 4 |
SCHW
Charles Schwab
SCHW
|
+$193M |
| 5 |
Clarivate
CLVT
|
+$158M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.25B |
| 2 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$809M |
| 3 |
Willis Towers Watson
WTW
|
+$664M |
| 4 |
AstraZeneca
AZN
|
+$658M |
| 5 |
Microsoft
MSFT
|
+$573M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.19% |
| 2 | Financials | 6.48% |
| 3 | Consumer Discretionary | 5.4% |
| 4 | Healthcare | 5.05% |
| 5 | Communication Services | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MCHB
3376
Mechanics Bancorp
MCHB
$3.72B
| $654K | ﹤0.01% |
15,899
-4,380
| -22% | -$171K |
|
|
POSH
3377
DELISTED
Poshmark, Inc. Class A Common Stock
POSH
| $653K | ﹤0.01% |
27,501
+27,134
| +7,393% | +$869K |
|
|
AIMC
3378
DELISTED
Altra Industrial Motion Corp
AIMC
| $652K | ﹤0.01% |
11,787
+2,824
| +32% | +$168K |
|
3379
iShares MSCI Australia ETF
EWA
$1.39B
| $648K | ﹤0.01% |
26,089
-183,058
| -88% | -$4.73M |
|
|
DISH
3380
CALL
DELISTED
DISH Network Corp.
DISH
| $648K | ﹤0.01% |
+14,900
| New | +$634K |
|
3381
AdvanSix
ASIX
$541M
| $647K | ﹤0.01% |
16,277
+487
| +3% | +$16.7K |
|
3382
GATX Corp
GATX
$6.35B
| $646K | ﹤0.01% |
7,205
-12,089
| -63% | -$1.08M |
|
3383
iShares Fallen Angels USD Bond ETF
FALN
$1.63B
| $644K | ﹤0.01% |
21,385
+3,992
| +23% | +$120K |
|
3384
Schwab International Small-Cap Equity ETF
SCHC
$5.39B
| $644K | ﹤0.01% |
15,519
+14,143
| +1,028% | +$601K |
|
|
TDAY
3385
USA Today Co
TDAY
$1.27B
| $643K | ﹤0.01% |
96,258
+21,080
| +28% | +$124K |
|
3386
IDEAYA Biosciences
IDYA
$3.42B
| $643K | ﹤0.01% |
25,224
+21,894
| +657% | +$511K |
|
3387
PUT
Pebblebrook Hotel Trust
PEB
$2.15B
| $643K | ﹤0.01% |
28,700
| – | – |
|
|
LGF.B
3388
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $642K | ﹤0.01% |
49,398
-50,852
| -51% | -$669K |
|
|
CONN
3389
DELISTED
Conn's Inc.
CONN
| $642K | ﹤0.01% |
28,129
+4,504
| +19% | +$107K |
|
3390
Vaxcyte
PCVX
$7.81B
| $641K | ﹤0.01% |
25,274
-59,741
| -70% | -$1.45M |
|
|
ABCM
3391
DELISTED
Abcam PLC
ABCM
| $641K | ﹤0.01% |
31,609
-2,315
| -7% | -$46.1K |
|
|
BTRS
3392
DELISTED
BTRS Holdings Inc. Class 1 Common Stock
BTRS
| $640K | ﹤0.01% |
60,146
+1,782
| +3% | +$20.6K |
|
3393
Ashland
ASH
$3.33B
| $638K | ﹤0.01% |
7,160
-4,616
| -39% | -$405K |
|
3394
iShares JPMorgan EM Local Currency Bond ETF
LEMB
$741M
| $637K | ﹤0.01% |
15,044
-7,378
| -33% | -$319K |
|
3395
E.W. Scripps
SSP
$257M
| $635K | ﹤0.01% |
35,176
+2,569
| +8% | +$47.5K |
|
3396
Penumbra
PEN
$12.7B
| $634K | ﹤0.01% |
2,380
-993
| -29% | -$267K |
|
|
TRIL
3397
DELISTED
Trillium Therapeutics Inc.
TRIL
| $634K | ﹤0.01% |
36,104
+30,448
| +538% | +$356K |
|
3398
BancFirst
BANF
$3.79B
| $633K | ﹤0.01% |
10,537
-10,797
| -51% | -$617K |
|
3399
The GEO Group
GEO
$4.13B
| $633K | ﹤0.01% |
84,848
-18,079
| -18% | -$133K |
|
3400
John Wiley & Sons Class A
WLY
$2.65B
| $633K | ﹤0.01% |
12,117
-4,220
| -26% | -$242K |
|
Similar funds
Citigroup's Q3 2021 Portfolio in Review
As of Q3 2021, Citigroup held 6,611 positions worth $169B, up 1.9% from $166B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Citigroup deployed $5.8B of net new capital in Q3 2021, opening 423 new positions and adding to 2,034 existing holdings. Its largest new stake was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
By sector, the portfolio is most concentrated in Technology at 11% of assets, down from 12% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $2.25B trimmed.
- Citigroup's largest Q3 2021 buy was Hennessy Capital Investment Corp. VI Unit: 9,095,000 shares worth $90.5M.
- Citigroup added most to Invesco Dorsey Wright Momentum ETF in Q3 2021, an estimated $591M increase.
- Citigroup's biggest Q3 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.25B.
- Citigroup fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $809M.
- Citigroup's ten largest holdings make up 25% of its $169B portfolio in Q3 2021.
- Citigroup opened 423 new positions and closed 793 in Q3 2021.
- Citigroup's portfolio value rose 1.9% quarter-over-quarter to $169B.
Based on Citigroup's 13F filing for Q3 2021, filed 10 Nov 2021.